The revised definition of pulmonary hypertension: exploring the impact on patient management
Open Access
- 1 December 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal Supplements
- Vol. 21 (Supplement) , K4-K8
Abstract
At the 6th World Symposium on Pulmonary Hypertension (PH), it was proposed that the mean pulmonary arterial pressure (mPAP) threshold used to define PH should be lowered from ≥25 mmHg to >20 mmHg. The rationale for this change is that the ≥25 mmHg threshold is arbitrary, whereas the revised threshold is based on scientific evidence. For the definition of all forms of pre-capillary PH, the inclusion of a pulmonary vascular resistance (PVR) ≥3 Wood Units was also proposed, placing greater emphasis on an elevated PVR to identify pulmonary vascular disease. Here, we discuss the possible impact of the revised definition of PH on future clinical management. This change may facilitate earlier PH detection, particularly in at-risk patient groups that are already undergoing screening programmes, e.g. those with systemic sclerosis or mutations associated with PH. As an mPAP above the upper limit of normal (>20 mmHg) but <25 mmHg is associated with increased risk of morbidity and mortality compared with a normal mPAP, early identification of patients in this group is important to enable close monitoring and timely treatment initiation once clinically indicated. Treatments currently approved for PH are not necessarily suitable for patients with an mPAP 21–24 mmHg, as the management of this group has not been widely examined. The revised definition may facilitate inclusion of these patients in prospective trials, allowing the evaluation of appropriate management strategies.Keywords
Funding Information
- Actelion Pharmaceuticals Ltd
This publication has 27 references indexed in Scilit:
- 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertensionEuropean Heart Journal, 2015
- Characterization of Patients With Borderline Pulmonary Arterial PressureChest, 2014
- Outcome of pulmonary endarterectomy in symptomatic chronic thromboembolic diseaseEuropean Respiratory Journal, 2014
- Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT studyAnnals of the Rheumatic Diseases, 2014
- Clinical Characterization and Survival of Patients with Borderline Elevation in Pulmonary Artery PressurePulmonary Circulation, 2013
- Borderline Mean Pulmonary Artery Pressure in Patients With Systemic Sclerosis: Transpulmonary Gradient Predicts Risk of Developing Pulmonary HypertensionArthritis & Rheumatism, 2012
- Pulmonary arterial hypertension therapy may be safe and effective in patients with systemic sclerosis and borderline pulmonary artery pressureArthritis & Rheumatism, 2012
- Diagnosis and Assessment of Pulmonary Arterial HypertensionJACC, 2009
- Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic reviewEuropean Respiratory Journal, 2009
- Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trialThe Lancet, 2008